tiprankstipranks
Moleculin Biotech (MBRX)
NASDAQ:MBRX

Moleculin Biotech (MBRX) Ownership - Who Owns Moleculin Biotech?

1,288 Followers

Moleculin Biotech (MBRX) Ownership Overview

2.59%3.90%13.12%80.39%
13.12% Other Institutional Investors
80.39% Public Companies and
Individual Investors
The ownership structure of Moleculin Biotech (MBRX) stock is a mix of institutional, retail and individual investors. Approximately 17.02% of the company’s stock is owned by Institutional Investors, 2.59% is owned by Insiders and 80.39% is owned by Public Companies and Individual Investors.
The ownership structure of Moleculin Biotech (MBRX) stock is a mix of institutional, retail and individual investors. Approximately 17.02% of the company’s stock is owned by Institutional Investors, 2.59% is owned by Insiders and 80.39% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Dec 27, 2023Bought$10000
Dec 27, 2023
Walter V Klemp
Ceo & President,director
Bought$129999
Dec 27, 2023Bought$20000

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
1,070,813.00Institution3.20%551,468.70
1,070,813.00Institution3.20%551,468.70
222,177.00Institution0.66%114,421.16
5,479.00Institution0.02%2,821.69
3,182.00Institution<0.01%1,638.73
1,608.00Institution<0.01%828.12
12.00Institution<0.01%6.18

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,070,813.00Institution3.20%551,468.70
222,177.00Institution0.66%114,421.16
5,479.00Institution0.02%2,821.69
3,182.00Institution<0.01%1,638.73
1,608.00Institution<0.01%828.12

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
616,108.00Institution1.84%310,518.00
454,705.00Institution1.36%229,171.00
12.00Institution<0.01%6.18

FAQ

Who Owns Moleculin Biotech (MBRX)?
According to the latest TipRanks data, approximately 13.12% of the company's stock is held by institutional investors, 2.59% is held by insiders, and 80.39% is held by retail investors.
    What percentage of Moleculin Biotech (MBRX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 13.12% of Moleculin Biotech (MBRX) stock is held by institutional investors.
      What percentage of Moleculin Biotech (MBRX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 80.39% of Moleculin Biotech (MBRX) stock is held by retail investors.
        Who owns the most shares of Moleculin Biotech (MBRX)?
        Vanguard owns the most shares of Moleculin Biotech (MBRX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis